Mobile Lung Nodule Observatory for Worldwide, Evidenced-based Research (mLOWER)
Mobile Lung Nodule Observatory for Worldwide, Evidenced - Based Research
Sponsor: Chinese Alliance Against Lung Cancer
This observational or N/A phase trial investigates Solitary Pulmonary Nodule and is currently ongoing. Chinese Alliance Against Lung Cancer leads this study, which shows 9 recorded versions since 2015 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
9 versions recorded-
Dec 2025 — Present [monthly]
Unknown
Status: Recruiting → Unknown
-
Sep 2025 — Dec 2025 [monthly]
Recruiting
-
Sep 2024 — Sep 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Jan 2021 — Jul 2024 [monthly]
Recruiting
▶ Show 4 earlier versions
-
Sep 2018 — Jan 2021 [monthly]
Recruiting
-
Jun 2018 — Sep 2018 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
Oct 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Chinese Alliance Against Lung Cancer
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Beijing, China , Cangzhou, China , Changsha, China , Chaoyang, China , Chengdu, China , Chongqing, China , Dalian, China , Guizhou, China , Hangzhou, China , Kunming, China and 16 more locations